Invention Grant
US07019136B2 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
失效
8-喹啉黄嘌呤和8-异喹啉黄嘌呤衍生物作为PDE 5抑制剂
- Patent Title: 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
- Patent Title (中): 8-喹啉黄嘌呤和8-异喹啉黄嘌呤衍生物作为PDE 5抑制剂
-
Application No.: US10937639Application Date: 2004-09-09
-
Publication No.: US07019136B2Publication Date: 2006-03-28
- Inventor: Gurdip Bhalay , Stephen Paul Collingwood , Robin Alec Fairhurst , Sylvie Felicite Gomez , Reto Naef , David Andrew Sandham
- Applicant: Gurdip Bhalay , Stephen Paul Collingwood , Robin Alec Fairhurst , Sylvie Felicite Gomez , Reto Naef , David Andrew Sandham
- Applicant Address: CH Basel
- Assignee: Novartis, AG
- Current Assignee: Novartis, AG
- Current Assignee Address: CH Basel
- Agent Gregory C. Houghton
- Priority: GB0008694 20000407
- Main IPC: C07D239/02
- IPC: C07D239/02

Abstract:
A compound of formula (I): R1 is hydrogen or alkyl optionally substituted by hydroxy, alkoxy, or alkylthio, R2 is hydrogen, alkyl, hydroxyalkyl, alkylcarbonyloxyalkyl, alkoxyalkyl, alkylthioalkyl, alkenyl, cycloalkylalkyl, heterocyclylalkyl, aralkyl in which the aryl ring thereof is optionally fused to a 5-membered heterocyclic group or is optionally substituted by one or more substituents selected from alkoxy, amino, alkylamino, dialkylamino, acylamino, halogen, hydroxy, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, alkylsulfonylamino or dialkylaminosulfonylamino, R3 is hydrogen or alkyl optionally substituted by hydroxy, alkoxy, or alkylthio, R4 is hydrogen or alkyl, R5 is a quinolinyl, isoquinolinyl or oxodihydroisoquinolinyl group optionally fused to a 5-membered heterocyclic group and optionally substituted by one or more substituents selected from halogen, cyano, hydroxy, alkyl, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl, alkoxy, alkylthio, alkenyl, alkoxycarbonyl, alkynyl, carboxyl, acyl, a group of formula —N(R6)R7, aryl optionally substituted by one or more substituents selected from halogen or alkoxy, or heteroaryl having 5 or 6 ring atoms attached through a ring carbon atom to the indicated carbon atom, and R6 and R7 are each independently hydrogen or alkyl optionally substituted by hydroxy or alkoxy or one of R6 and R7 is hydrogen and the other is acyl, or R6 and R7 together with the nitrogen atom to which they are attached denote a 5- or 6-membered heterocyclyl group.
Public/Granted literature
- US20050054660A1 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors Public/Granted day:2005-03-10
Information query